Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Serological Response in Lung Transplant Recipients after Two Doses of SARS-CoV-2 mRNA Vaccines

Background: Lung-transplant (LT) recipients are at high risk for COVID-19 due to immunosuppression and respiratory tropism of SARS-CoV-2. The information on the effect of COVID-19 mRNA vaccines to elicit immunogenic responses after a two-dose (2D) regimen in LT recipients is sparse. Thus, we assesse...

Full description

Bibliographic Details
Main Authors: Madhusudhanan Narasimhan, Lenin Mahimainathan, Andrew E Clark, Amena Usmani, Jing Cao, Ellen Araj, Fernando Torres, Ravi Sarode, Vaidehi Kaza, Chantale Lacelle, Alagarraju Muthukumar
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
lung transplantation
SARS-CoV-2
IgG
IgM
Spike
nucleocapsid
Online Access:https://www.mdpi.com/2076-393X/9/7/708

Internet

https://www.mdpi.com/2076-393X/9/7/708

Similar Items